Sino Biological, Inc. has made significant strides in the field of biotechnology with the recent launch of its SwiftFluo® TR-FRET Kinase Assay Kits. This cutting-edge product represents a paradigm shift for researchers focused on kinase activity detection and inhibitor screening strategies. These assays are designed to provide ready-to-use solutions that boast high performance and efficiency.
Utilizing advanced Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) technology, the SwiftFluo® kits are characterized by their exceptional sensitivity and low background noise, setting a new benchmark for accuracy in high-throughput screening. Researchers have long sought methods to streamline kinase inhibitor screenings, and these kits meet this need by outpacing traditional techniques like radioactive assays, ELISA, and fluorescence intensity methods.
The comprehensive range of these assay kits allows for the profiling of over 60 tyrosine kinases (TKs), 150 serine/threonine kinases (STKs), and 15 cyclin-dependent kinases (CDKs). This breadth of coverage enables researchers to explore many essential signaling pathways, making these kits a versatile tool for drug discovery.
Alongside the kits, Sino Biological offers an array of associated substrates and standalone active kinases, enhancing flexibility for custom assays. As Dr. Rob Burgess, Chief Business Officer at Sino Biological US, points out, researchers can now execute homogeneous, no-wash assays using a straightforward add-and-read format compatible with standard High-Throughput Screening (HTS) platforms. This innovation not only cuts down on assay development time but also optimizes laboratory workflows.
"We are thrilled to introduce SwiftFluo® TR-FRET kits as an impactful resource for the global research community," states Dr. Jie Zhang, General Manager of Sino Biological. He highlights the careful design of the kits, which ensures ease of use, cost-effectiveness, and reproducibility - factors that are critical to the success of high-throughput screening campaigns.
These advancements position Sino Biological at the forefront of biotechnological innovation. Researchers eager to delve into kinase drug discovery can explore the capabilities of the SwiftFluo® TR-FRET kits by visiting
www.sinobiological.com or downloading the technical QA handbook available online.
Founded in 2007, Sino Biological has made its mark as a global biotechnology leader providing high-quality recombinant proteins, antibodies, and contract research services. With reach extending to over 90 countries, the company plays a vital role in supporting diverse research areas including drug discovery, vaccine development, and diagnostics. Its product portfolio and innovative research platforms are tailored to meet the demands of researchers worldwide.
In summary, the launch of the SwiftFluo® TR-FRET kits opens new avenues for efficient kinases screening. The promise of enhanced data reproducibility and streamlined workflows stands to significantly impact how researchers approach kinase studies, underscoring Sino Biological's commitment to advancing biotechnological research on a global scale.